Neurovascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By Therapeutic Application, By End User, By Region and Competition, 2020-2030F

Description

The Global Neurovascular Devices Market was valued at USD 7.48 Billion in 2024 and is projected to reach USD 10.52 Billion by 2030, growing at a CAGR of 5.82%. This market is expanding rapidly, fueled by the increasing prevalence of neurovascular conditions such as strokes, aneurysms, and arteriovenous malformations. As medical systems prioritize early intervention, there is a growing need for advanced neurovascular technologies that facilitate prompt and minimally invasive treatments. Technological progress in imaging, catheter systems, and stent retrieval methods has significantly enhanced patient outcomes and procedural efficiency. Rising awareness among healthcare professionals and patients regarding the benefits of minimally invasive procedures is also contributing to broader adoption. Additionally, the growing elderly population, which is more prone to neurological ailments, is further driving demand for specialized neurovascular solutions that promote faster recovery and reduce surgical risks.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 7.48 Billion
Market Size 2030	USD 10.52 Billion
CAGR 2025-2030	5.82%
Fastest Growing Segment	Cerebral Aneurysm
Largest Market	North America

Key Market Drivers

Rising Incidence of Stroke and Neurovascular Disorders

The increasing frequency of strokes and related neurovascular disorders is a major force behind the market's growth. Globally, strokes remain a leading cause of mortality and long-term disability, with over 12 million first-time stroke cases reported each year and around 6.5 million resulting in death, according to the World Stroke Organization. A significant proportion of these cases affect individuals under 70, and even a growing number under 50, underscoring the widespread nature of the issue. This surge in neurological conditions has accelerated the demand for prompt, minimally invasive interventions using advanced devices such as thrombectomy catheters, flow diverters, and embolization coils. These tools are essential for quickly restoring cerebral blood flow and reducing damage, ultimately leading to improved recovery outcomes. Furthermore, increased investment in specialized stroke centers and neurointervention capabilities is ensuring broader access to high-performance devices and timely care.

Key Market Challenges

High Cost of Devices and Procedures

The substantial cost associated with neurovascular devices and procedures remains a critical obstacle for the market. Products like stent retrievers, embolization coils, and flow diverters involve complex engineering and premium materials, which contribute to their elevated prices. For example, a Pipeline Embolization Device can cost upwards of USD 27,000, and the comprehensive cost of mechanical thrombectomy per patient often exceeds USD 285,000. These financial demands are compounded by the need for specialized imaging systems, trained professionals, and extended care, further inflating treatment expenses. Access is particularly constrained in low- and middle-income countries, while reimbursement inconsistencies in developed markets can also deter adoption. The financial burden on healthcare systems and patients continues to challenge the broader implementation of advanced neurovascular solutions.

Key Market Trends

Rising Adoption of Artificial Intelligence (AI) and Image-Guided Navigation

A prominent trend shaping the neurovascular devices market is the growing incorporation of Artificial Intelligence (AI) and image-guided navigation technologies. These innovations are enhancing diagnostic and procedural precision by enabling real-time visualization and data-driven decision-making. AI systems assist in the rapid interpretation of complex imaging data, improving detection and treatment planning for conditions such as aneurysms and strokes. Image-guided navigation facilitates safer and more effective placement of devices like stents and catheters by offering detailed vascular mapping. The integration of AI with high-resolution imaging technologies-such as MRI and CT angiography-not only supports personalized treatment strategies but also predicts outcomes and identifies risks before procedures begin. These advancements are streamlining workflows, reducing error rates, and promoting better clinical results, while continued investments in AI-driven platforms are expected to further accelerate innovation and adoption.

Key Market Players

Medtronic plc
Stryker Corporation
Terumo Corporation
Penumbra, Inc.
Johnson & Johnson Services, Inc.
Integra LifeSciences Corporation
Acandis GmbH
Spiegelberg GmbH & Co. KG
MicroPort Scientific Corporation
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Report Scope

In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurovascular Devices Market, By Device:

Cerebral Embolization and Aneurysm Coiling Devices
Cerebral Angioplasty and Stenting Systems
Neurothrombectomy Devices
Support Devices
Trans Radial Access Devices

Neurovascular Devices Market, By Therapeutic Application:

Stroke
Cerebral Artery
Cerebral Aneurysm
Others

Neurovascular Devices Market, By End User:

Hospitals
Specialty Clinics
Others

Neurovascular Devices Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Devices Market.

Available Customizations

Global Neurovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Neurovascular Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
- 5.2.2. By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
- 5.2.3. By End User (Hospitals, Specialty Clinics, Others)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
5.3. Market Map

6. North America Neurovascular Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Device
- 6.2.2. By Therapeutic Application
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Neurovascular Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Device
    - 6.3.1.2.2. By Therapeutic Application
    - 6.3.1.2.3. By End User
- 6.3.2. Mexico Neurovascular Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Device
    - 6.3.2.2.2. By Therapeutic Application
    - 6.3.2.2.3. By End User
- 6.3.3. Canada Neurovascular Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Device
    - 6.3.3.2.2. By Therapeutic Application
    - 6.3.3.2.3. By End User

7. Europe Neurovascular Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Device
- 7.2.2. By Therapeutic Application
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Neurovascular Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Device
    - 7.3.1.2.2. By Therapeutic Application
    - 7.3.1.2.3. By End User
- 7.3.2. Germany Neurovascular Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Device
    - 7.3.2.2.2. By Therapeutic Application
    - 7.3.2.2.3. By End User
- 7.3.3. United Kingdom Neurovascular Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Device
    - 7.3.3.2.2. By Therapeutic Application
    - 7.3.3.2.3. By End User
- 7.3.4. Italy Neurovascular Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Device
    - 7.3.4.2.2. By Therapeutic Application
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Neurovascular Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Device
    - 7.3.5.2.2. By Therapeutic Application
    - 7.3.5.2.3. By End User

8. Asia-Pacific Neurovascular Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Device
- 8.2.2. By Therapeutic Application
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Neurovascular Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Device
    - 8.3.1.2.2. By Therapeutic Application
    - 8.3.1.2.3. By End User
- 8.3.2. India Neurovascular Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Device
    - 8.3.2.2.2. By Therapeutic Application
    - 8.3.2.2.3. By End User
- 8.3.3. South Korea Neurovascular Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Device
    - 8.3.3.2.2. By Therapeutic Application
    - 8.3.3.2.3. By End User
- 8.3.4. Japan Neurovascular Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Device
    - 8.3.4.2.2. By Therapeutic Application
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Neurovascular Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Device
    - 8.3.5.2.2. By Therapeutic Application
    - 8.3.5.2.3. By End User

9. South America Neurovascular Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Device
- 9.2.2. By Therapeutic Application
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Neurovascular Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Device
    - 9.3.1.2.2. By Therapeutic Application
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Neurovascular Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Device
    - 9.3.2.2.2. By Therapeutic Application
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Neurovascular Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Device
    - 9.3.3.2.2. By Therapeutic Application
    - 9.3.3.2.3. By End User

10. Middle East and Africa Neurovascular Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Device
- 10.2.2. By Therapeutic Application
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Neurovascular Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Device
    - 10.3.1.2.2. By Therapeutic Application
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Neurovascular Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Device
    - 10.3.2.2.2. By Therapeutic Application
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Neurovascular Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Device
    - 10.3.3.2.2. By Therapeutic Application
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Medtronic plc
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Stryker Corporation
15.3. Terumo Corporation
15.4. Penumbra, Inc.
15.5. Johnson & Johnson Services, Inc.
15.6. Integra LifeSciences Corporation
15.7. Acandis GmbH
15.8. Spiegelberg GmbH & Co. KG
15.9. MicroPort Scientific Corporation
15.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.